Table 4.
Relationship of demographics and clinical characteristics to perceived overall impact of myelosuppressi
| Patients, n | Minor impact, n (%) | Moderate impact, n (%) | Major impact, n (%) | p value | |
|---|---|---|---|---|---|
| All patients | 301 | 36 (12) | 146 (48.5) | 119 (39.5) | – |
| Age | |||||
| < 50 years | 191 | 15 (8) | 98 (51) | 78 (41) | 0.01 |
| ≥ 50 years | 110 | 21 (19) | 48 (44) | 41 (37) | |
| Gender | |||||
| Male | 120 | 19 (16) | 61 (51) | 40 (33) | 0.26 |
| Female | 180 | 17 (9) | 84 (47) | 79 (44) | |
| Working status | |||||
| Working | 181 | 19 (11) | 93 (51) | 69 (38) | 0.40 |
| Not working | 120 | 17 (14) | 53 (44) | 50 (42) | |
| Cancer type | |||||
| Breast | 153 | 15 (10) | 75 (49) | 63 (41) | 0.59 |
| Lung | 100 | 13 (13) | 46 (46) | 41 (41) | |
| Colorectal | 48 | 8 (17) | 25 (52) | 15 (31) | |
| Comorbidities | |||||
| Depression | |||||
| Yes | 85 | 6 (7) | 46 (54) | 33 (39) | 0.20 |
| No | 216 | 30 (14) | 100 (46) | 86 (40) | |
| Diabetes | |||||
| Yes | 91 | 8 (9) | 46 (51) | 37 (41) | 0.54 |
| No | 210 | 28 (13) | 100 (48) | 82 (39) | |
| Hypertension | |||||
| Yes | 69 | 9 (13) | 33 (48) | 27 (39) | 0.95 |
| No | 232 | 27 (12) | 113 (49) | 92 (40) | |